AstraZeneca Pharmaceuticals LP
NEWS
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 10, 2020.
Researchers with The U.S. Oncology Network discovered AstraZeneca’s Calquence (acalabrutinib) benefited a small number of patients who have severe infections of the novel coronavirus.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 8, 2020.
Shares of Gilead Sciences jumped in pre-market trading this weekend following reports that the company has been approached by U.K. pharma giant AstraZeneca regarding a potential merger.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 5, 2020.
UK-based AstraZeneca and the University of Oxford have partnered on the global development and distribution of Oxford’s COVID-19 vaccine, AZD1222.
Accent Therapeutics and AstraZeneca forged a collaboration valued at about $1.1 billion to discover, develop and commercialize transformative therapeutics targeting RNA-modifying proteins for the treatment of cancer.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 4, 2020.
Less than one month after the White House zeroed in on 14 vaccine candidates for COVID-19, the administration has narrowed that list even more to five potential treatments for the prevention of the novel coronavirus.
JOBS
IN THE PRESS